Clark K L, Robertson M J, Drew G M
Department of Peripheral Pharmacology, Glaxo Group Research Limited, Ware, Hertfordshire, England.
J Cardiovasc Pharmacol. 1992 Apr;19(4):515-24. doi: 10.1097/00005344-199204000-00007.
Experiments were performed in anesthetized cats to compare the characteristics of angiotensin receptors in the renal and mesenteric vascular beds. Injection of either angiotensin II (Ang II; 0.3-30 ng) or angiotensin III (Ang III; 0.3-30 ng) directly into the superior mesenteric or renal artery caused dose-related, reproducible reductions in mesenteric and renal blood flow, respectively. Ang II and Ang III were equipotent as vasoconstrictors in both vascular beds. The peptide angiotensin receptor antagonists saralasin and Ile7-Ang III (1 microgram/kg/min intravenously, i.v.) and the nonpeptide angiotensin receptor antagonist DuP 753 (3 mg/kg plus 20 micrograms/kg/min i.v.) caused a rightward displacement of dose-response curves to Ang II or Ang III in both the mesenteric and renal vasculature. Vasoconstrictor responses to Ang II or Ang III in either vascular bed were blocked to similar extents by each antagonist. In separate cats, the dose of the antagonists required to cause a 10-fold rightward displacement of the Ang II dose-response curve (DR10) in both vascular beds was determined. The DR10 values indicated that the potency of each antagonist was similar in the renal and mesenteric vascular beds. These results provide no evidence to suggest that angiotensin receptors mediating vasoconstriction in the renal and mesenteric vasculature have different characteristics.
在麻醉猫身上进行实验,以比较肾血管床和肠系膜血管床中血管紧张素受体的特性。向上肠系膜动脉或肾动脉直接注射血管紧张素II(Ang II;0.3 - 30 ng)或血管紧张素III(Ang III;0.3 - 30 ng),分别导致肠系膜血流和肾血流呈剂量相关的、可重复的减少。在两个血管床中,Ang II和Ang III作为血管收缩剂的效力相当。肽类血管紧张素受体拮抗剂沙拉新和Ile7 - Ang III(静脉注射1微克/千克/分钟)以及非肽类血管紧张素受体拮抗剂DuP 753(3毫克/千克加20微克/千克/分钟静脉注射),使肠系膜血管和肾血管中对Ang II或Ang III的剂量反应曲线向右移位。每种拮抗剂对任一血管床中Ang II或Ang III的血管收缩反应的阻断程度相似。在另外的猫身上,测定了在两个血管床中使Ang II剂量反应曲线(DR10)向右移位10倍所需的拮抗剂剂量。DR10值表明每种拮抗剂在肾血管床和肠系膜血管床中的效力相似。这些结果没有提供证据表明介导肾血管和肠系膜血管收缩的血管紧张素受体具有不同的特性。